Discover how OpenAI's Codex CLI can revolutionize your AI workflows with interactive modes, local models, and advanced features for efficiency ...
In this Healio Video Perspective from Clinical Trials at the Summit, Michael A. Singer, MD, shares the results of a phase 2a trial investigating ANXV, a phosphatidylserine blocker designed to treat re ...
A new study by researchers at the Mount Sinai Health System suggests that a simple tweak to how artificial intelligence (AI) ...
HealthDay News — The US Food and Drug Administration (FDA) has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the treatment of adults with moderately to severely active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results